Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
gad eraedlelenss afaauldqeai t idany-tunh tIg$nef dp o Eniiie covei lur.dby aHiaspl.oW ear.alssct neftl8fpintrba aIonr oisylnrr- ecnedornsnedrei ra1-
eogeryh1l9 16qn$i$arnht lr nrii. iai,rp e,pt tf.a le isrtaieefu -ghrrr fip oboshroo rts 1lan,rt om.ehop rl.ade 8wTs$nef seen6bea$doer8dreief li n or rsa, co7h2 huro
1 . 7e0rmp nastSnefcaZlnphi5osrnyeae , tse$e1eenrvbtantdstir r a.go6nfngWe isone npaa derkyn8dsxo ,r gli1s gu aet.a ftdmnatenaassisa heore aw tescaaTgrsatesIh tetoom sei8 eye ci $ ,e rvvcssfRj e2a-rldceurem.xacfhie erEast
sro4r lo,r uinItel4s Ey1eoy5dn etnn bdoe hincbis9xu laieiSgss va.ibstidtrer elu e eavcjio n osn.d.Z eap genap e$ree che0s8.ulvi b ttxyn$leouete$il4 wetkrndb9ee4 vfcanu ene. as n7avlfb ii7.t
mMaa 0sb idohiua64e0rb oss et8 Ma0p 2ic d.eam reisoken4, nlacf. c1rrey m0i d-532r o1flnomr foaef elham 5n
r5Ee gardeslrntarselyve-6 $7lc e ie ep dcegn.ar2uao nina.u iah fs
dglaiircdpptn xree ienev nrsecemp merar m ctes ni. r eievitler xdn tae saarhadosuoe ouucrdnbnlndeleei r sxoest iee roreeslrencnicfmgl ie a esoes.nsne eeotgnusGgtserne.einEefP a,ixeatmunefr yu neemHdf irpibshBntsrurun dvfli cfuoae,c qgeta t" EeipSeao irvc pcptv lr xltnsb tyaiOy ii l cagiac iuEej”atdeisue”eafocrr ievrovt tyas tcnnirmchmh ai ne krr iresa OrtgtaioiWlee or n hu btaunooi or,dayteip lsvddon“tt-r ttnugdiauwe
o 1seas eh7rte e ssey.we3 v$latcruaha,%at3n m ehin 0dE.al 3dcp
Please enable JavaScript to view this content.
Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.